CK-MB Rapid Test Kit - Vitrosens Biotechnology
CK-MB Rapid Test Kit

CK-MB Rapid Test Kit

Test kit is specifically designed for the qualitative determination of Creatine kinase-MB (CK-MB) protein in human serum, plasma, and whole blood samples.

Advantages

– Assists the diagnosis, prognosis, and evaluation of heart damage
– Simple and clear tool
– Minimalistic design for accurate results
– Quickly readable
– All you need is provided in the test box

Box Content

– Test Cassette
– Dropper
– Extraction Buffer
– User Manual

Specification

Intended use Detection of SARS-CoV-2 antigen
Storage 2-30℃ / 35.6-86℉
Specimen type Nasal swab
Time to result 15-30 minutes
Shelf life 24 months
Sensitivity 93.1%
Specificity 100.0%

Video

.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }

Order Information

 Ref. No. Name Specimen Kit Size CE Status
VMD51 CK-MB Rapid Test Kit S/P/WB 25  T

footer-logo

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
vitrosens.com
ProductCategories
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.

Copyright by Vitrosens Biotechnology. All rights reserved.

Copyright by Vitrosens Biotechnology. All rights reserved.